Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Sun Pharma Inds
Join Channel
Consolidated Standalone

Sun Pharma Inds.

₹1841.5 23.9 | 1.3%

Market Cap ₹441838 Cr.

Stock P/E 45.8

P/B 18.7

Current Price ₹1841.5

Book Value ₹ 98.3

Face Value 1

52W High ₹1960.2

Dividend Yield 0.73%

52W Low ₹ 1241.4

Edit Ratio

Sun Pharma Inds. Research see more...

Overview Inc. Year: 1993Industry: Pharmaceuticals & Drugs

Sun Pharmaceutical Industries Ltd is an multinational pharmaceutical company. The Company is engaged in the business of manufacturing, growing and marketing various generic formulations. It produces a portfolio of generic and speciality medicines concentrated on a spectrum of chronic and acute treatments. The Company's product portfolio consists of generics, branded generics, over-the-counter (OTC)/client healthcare products, speciality, anti-retrovirals (ARVs), active pharmaceutical elements (APIs) and intermediates. Its over the counter brands includes Faringosept , Revital, and Volini. The Company offers its products in types of dosage forms, which includes capsules, pills, sprays, injectables, inhalers, ointments, creams and beverages. Its portfolio of speciality merchandise, branded generics are available in 100 international locations. The Company operates production sites across 6 continents.

Read More..

Sun Pharma Inds. Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Sun Pharma Inds. Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Sun Pharma Inds. Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 2829 8028 7733 7684 8982 10303 12532 14116 15586 20812 20275
Other Income 178 220 445 690 1252 1286 1511 192 1197 329 553
Total Income 3007 8249 8178 8374 10234 11589 14043 14308 16783 21141 20829
Total Expenditure 2812 8596 8152 7745 8128 8562 9820 11859 12917 14390 14775
Operating Profit 195 -347 26 629 2106 3028 4223 2449 3865 6752 6053
Interest 18 551 574 224 388 541 408 268 388 472 784
Depreciation 102 661 464 422 487 553 562 1236 1350 1601 1601
Exceptional Income / Expenses -2876 0 -70 0 -951 -1214 0 -90 -1821 -2938 -219
Profit Before Tax -2801 -1559 -1082 -17 280 719 3253 856 307 1741 3450
Provision for Tax 27 -85 5 6 -25 -97 42 13 407 50 591
Profit After Tax -2829 -1474 -1088 -23 306 817 3211 842 -100 1691 2858
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -2829 -1474 -1088 -23 306 817 3211 842 -100 1691 2858
Adjusted Earnings Per Share -13.7 -7.1 -4.5 -0.1 1.3 3.4 13.4 3.5 -0.4 7 11.9

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -3% 13% 14% 22%
Operating Profit CAGR -10% 35% 15% 41%
PAT CAGR 69% 50% 28% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 48% 32% 34% 9%
ROE Average 12% 6% 7% -1%
ROCE Average 13% 7% 8% 1%

Sun Pharma Inds. Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 7408 22786 21891 21012 22323 22844 24396 26938 24588 23748 23694
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 5 1170 1923 761 1565 1423 1257 5300 4866 7587 11036
Other Non-Current Liabilities 2978 3526 2163 1474 684 514 1891 1928 1498 1623 2810
Total Current Liabilities 4233 11052 8627 10963 12558 13272 11204 9951 10106 8365 4445
Total Liabilities 14624 38535 34604 34210 37130 38052 38747 44118 41058 41324 41985
Fixed Assets 1267 3185 3575 4039 4645 4978 5229 9669 9713 8712 7737
Other Non-Current Assets 7658 29899 25713 23783 22910 21904 21577 21719 21641 16147 19294
Total Current Assets 5699 5450 5316 6388 9575 11170 11941 12730 9704 16444 14913
Total Assets 14624 38535 34604 34210 37130 38052 38747 44118 41058 41324 41985

Sun Pharma Inds. Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 222 76 121 141 148 98 303 315 351 420 410
Cash Flow from Operating Activities -2405 149 -1254 -1621 -1171 1242 1306 -417 7636 507 -292
Cash Flow from Investing Activities 519 2153 3639 2381 1392 434 1479 1464 -2702 -705 -263
Cash Flow from Financing Activities 1742 -2674 -2368 -753 -272 -1469 -2871 -1000 -4871 169 474
Net Cash Inflow / Outflow -144 -373 17 7 -52 207 -86 48 63 -29 -81
Closing Cash & Cash Equivalent 76 193 138 148 98 303 221 351 420 410 326

Sun Pharma Inds. Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) -13.66 -7.12 -4.52 -0.1 1.27 3.4 13.38 3.51 -0.42 7.05 11.91
CEPS(Rs) -13.16 -3.93 -2.59 1.66 3.3 5.71 15.72 8.66 5.21 13.72 18.58
DPS(Rs) 1.5 3 1 3.5 2 2.75 4 7.5 10 11.5 13.5
Book NAV/Share(Rs) 35.77 109.74 90.94 87.57 93.04 95.21 101.68 112.28 102.48 98.98 98.76
Core EBITDA Margin(%) 0.58 -6.94 -5.32 -0.78 7.21 14.04 19.6 14.18 16.98 30.86 27.13
EBIT Margin(%) -95.03 -12.34 -6.46 2.65 5.64 10.16 26.46 7.05 4.42 10.63 20.88
Pre Tax Margin(%) -95.66 -19.08 -13.76 -0.22 2.36 5.8 23.51 5.37 1.95 8.37 17.01
PAT Margin (%) -96.59 -18.05 -13.83 -0.29 2.58 6.58 23.21 5.29 -0.64 8.12 14.1
Cash Profit Margin (%) -93.11 -9.96 -7.93 5.13 6.68 11.04 27.27 13.06 7.95 15.82 21.99
ROA(%) -23.44 -5.55 -2.97 -0.07 0.86 2.17 8.36 2.03 -0.23 4.1 6.86
ROE(%) -37.23 -9.78 -4.88 -0.11 1.41 3.62 13.6 3.28 -0.39 7 12.05
ROCE(%) -31.53 -5.11 -1.77 0.75 2.38 4.31 12.19 3.46 2.19 7.28 12.81
Receivable days 107.05 62.18 88.2 110.36 122.88 151.6 147.72 146.18 125.78 99.7 143.65
Inventory Days 111.38 69.43 100.29 103.99 68.38 72.52 71.57 69.43 79.29 64.83 66.72
Payable days 154.28 114.01 203.22 213.15 238.64 234.55 171.17 220.03 217.66 175.92 187.09
PER(x) 0 0 0 0 388.88 140.81 26.32 170.21 0 139.51 136.03
Price/Book(x) 16.03 9.32 9.01 7.85 5.32 5.03 3.46 5.32 8.93 9.93 16.41
Dividend Yield(%) 0.26 0.29 0.12 0.51 0.4 0.57 1.14 1.26 1.09 1.17 0.83
EV/Net Sales(x) 42.78 27.17 26.23 22.24 13.98 11.75 7.2 10.64 14.36 11.68 19.7
EV/Core EBITDA(x) 621.16 -628.52 7678.6 271.64 59.63 39.99 21.37 61.31 57.9 36 66
Net Sales Growth(%) 16.31 183.81 -3.68 -0.64 16.9 14.7 21.63 12.64 10.41 33.53 -2.58
EBIT Growth(%) -519.42 63.79 49.59 140.71 223.34 88.52 190.47 -69.32 -38.12 218.47 91.29
PAT Growth(%) -647.58 47.88 26.23 97.9 1438.18 167.18 293.23 -73.77 -111.87 1790.89 69.05
EPS Growth(%) -647.59 47.88 36.51 97.89 1438.13 167.17 293.23 -73.77 -111.87 1791.07 69.05
Debt/Equity(x) 0.33 0.3 0.27 0.29 0.31 0.28 0.26 0.26 0.2 0.32 0.47
Current Ratio(x) 1.35 0.49 0.62 0.58 0.76 0.84 1.07 1.28 0.96 1.97 3.36
Quick Ratio(x) 1.13 0.3 0.37 0.37 0.59 0.63 0.83 0.94 0.62 1.49 2.59
Interest Cover(x) -151.4 -1.83 -0.88 0.92 1.72 2.33 8.97 4.2 1.79 4.69 5.4
Total Debt/Mcap(x) 0.02 0.03 0.03 0.04 0.06 0.06 0.08 0.05 0.02 0.03 0.03

Sun Pharma Inds. Shareholding Pattern

# Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Promoter 54.48 54.48 54.48 54.48 54.48 54.48 54.48 54.48 54.48 54.48
FII 14.95 15.99 16.87 16.89 16.48 16.79 17.07 17.72 17.22 18.02
DII 19.66 19.64 19.14 19.24 19.75 19.67 19.52 18.82 19.28 18.61
Public 10.91 9.89 9.52 9.39 9.29 9.07 8.92 8.97 9.02 8.9
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 28% CAGR over last 5 years
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 6% over the last 3 years.
  • Debtor days have increased from 175.92 to 187.09days.
  • Stock is trading at 18.7 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sun Pharma Inds. News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!